Atlanta Capital Management Co. L L C raised its stake in Teleflex Incorporated (NYSE:TFX) by 2.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,519,464 shares of the medical technology company’s stock after purchasing an additional 64,985 shares during the quarter. Teleflex accounts for 3.1% of Atlanta Capital Management Co. L L C’s investment portfolio, making the stock its 2nd biggest holding. Atlanta Capital Management Co. L L C owned about 5.59% of Teleflex worth $523,444,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in shares of Teleflex by 5.2% in the 1st quarter. Vanguard Group Inc. now owns 3,781,475 shares of the medical technology company’s stock valued at $732,584,000 after purchasing an additional 186,845 shares during the last quarter. Janus Henderson Group PLC grew its stake in shares of Teleflex by 50,429.2% in the 2nd quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock valued at $377,296,000 after purchasing an additional 1,812,426 shares during the last quarter. State Street Corp grew its stake in shares of Teleflex by 1.8% in the 2nd quarter. State Street Corp now owns 1,399,922 shares of the medical technology company’s stock valued at $290,853,000 after purchasing an additional 25,401 shares during the last quarter. American Century Companies Inc. grew its stake in shares of Teleflex by 22.8% in the 2nd quarter. American Century Companies Inc. now owns 839,080 shares of the medical technology company’s stock valued at $174,327,000 after purchasing an additional 155,863 shares during the last quarter. Finally, FMR LLC grew its stake in shares of Teleflex by 46.5% in the 1st quarter. FMR LLC now owns 811,764 shares of the medical technology company’s stock valued at $157,263,000 after purchasing an additional 257,649 shares during the last quarter. Institutional investors own 89.75% of the company’s stock.

Teleflex Incorporated (TFX) traded down 0.80% during mid-day trading on Monday, hitting $244.07. The company had a trading volume of 65,919 shares. Teleflex Incorporated has a 52-week low of $136.53 and a 52-week high of $248.68. The stock’s 50 day moving average price is $228.55 and its 200 day moving average price is $209.38. The firm has a market cap of $10.99 billion, a P/E ratio of 46.68 and a beta of 1.07.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The business had revenue of $528.60 million during the quarter, compared to analyst estimates of $518.98 million. During the same period in the prior year, the company posted $1.89 EPS. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. On average, equities research analysts predict that Teleflex Incorporated will post $8.28 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Tuesday, August 15th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.55%. The ex-dividend date was Friday, August 11th. Teleflex’s dividend payout ratio (DPR) is 26.00%.

In related news, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $211.75, for a total value of $42,350.00. Following the completion of the transaction, the director now directly owns 8,080 shares of the company’s stock, valued at approximately $1,710,940. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 600 shares of company stock valued at $132,408 over the last three months. Corporate insiders own 2.39% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Atlanta Capital Management Co. L L C Has $523.44 Million Holdings in Teleflex Incorporated (TFX)” was posted by Watch List News and is the property of of Watch List News. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.watchlistnews.com/atlanta-capital-management-co-l-l-c-has-523-44-million-holdings-in-teleflex-incorporated-tfx/1620097.html.

TFX has been the topic of several analyst reports. Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $261.00 target price on the stock in a research note on Tuesday, September 12th. BidaskClub downgraded Teleflex from a “hold” rating to a “sell” rating in a research note on Tuesday, August 8th. Barclays PLC reiterated an “overweight” rating and issued a $253.00 target price (up from $230.00) on shares of Teleflex in a research note on Tuesday, September 12th. Needham & Company LLC reiterated a “buy” rating on shares of Teleflex in a research note on Friday, August 4th. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a $253.00 target price (up from $230.00) on shares of Teleflex in a research note on Wednesday, August 9th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. Teleflex presently has an average rating of “Buy” and a consensus target price of $260.75.

Teleflex Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.